Eric Niesor, PhD

Chairman & Founder

PhD from University in Geneva (Switzerland) and specialized in Molecular Biology, lipoprotein metabolism, Nutritional Biochemistry, Diabetology. Eric joined Roche for 12 years, first in charge of the Metabolic and Cardiovascular department. He later received the title of Roche Distinguished Scientist.

Renée Benghozi, MD

Co-founder

Renée is a cardiologist and graduate of the Université Paris XII (France). She has been practicing cardiology at the Hospital Henri Mondor (Créteil) since 1982. She is also an international clinical specialist who has over 30 years of experience in the clinical development of molecules in the cardiovascular and metabolic diseases field.

François Lamour, PhD

Co-founder

Francois holds a PhD in Molecular Biology from Université Henri Poincare (Nancy - France). He joined Roche in 1993 and held various Scientist roles including Clinical Team Leader. In 2015 he joined Cerenis Therapeutics as Senior VP Clinical Development to then move to Actelion (now Idorsia) as Director, Senior Clinical Project Scientist.

vincent fourcaut

Vincent is a Finance professional with 15 year experience having started his career as a financial analyst for Société Générale and later for Berenberg. In 2006 he moved to the investment side first at La Financière de l'Echiquier. In 2013 he founded and built Quantology Capital Management, a Paris-based investment company.